Pyrenacantha staudtii
Pyrenacantha staudtii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Pyrenacantha staudtii is a botanical species recognized for its diverse phytochemical profile and potential therapeutic applications. Research has identified key chemical constituents within the plant, including 3-pyridinecarboxylic acid, BETA-SITOSTEROL, and Taraxerol. Studies specifically focusing on the aqueous extract of the leaf have explored its efficacy in various medicinal contexts. These investigations often compare its effects against substances such as Aspirin, Indomethacin, and Reserpine to evaluate its pharmacological properties. Consequently, the plant is being studied for its ability to address conditions like dysmenorrhea.
- Synonyms
- Chlamydocarya Staudtii
- Common names
- Not available
- Family
- Icacinaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Pyrenacantha staudtii is a botanical subject that is frequently identified by its synonym, Chlamydocarya staudtii. While these two names may appear different, they both refer to the exact same plant species within scientific literature. Understanding this nomenclatural relationship is essential for researchers tracking the plant's classification history. Navigating these botanical synonyms ensures that accurate data is compiled regardless of which name is utilized. Consequently, recognizing this link helps prevent confusion when studying the diverse characteristics of this species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Pyrenacantha staudtii is a unique botanical specimen that belongs to the vast kingdom Plantae. Within this diverse biological realm, the plant is classified under the class Equisetopsida. It further falls into the order Icacinales, which helps scientists understand its evolutionary lineage. The species is a member of the Icacinaceae family, showcasing its specific morphological traits. Ultimately, it is defined by its placement within the genus Pyrenacantha.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Icacinales |
| Family | Icacinaceae |
| Genus | Pyrenacantha |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Pyrenacantha staudtii is a resilient species found across various diverse regions of the African continent. Its natural distribution spans from East Tropical Africa, specifically in Uganda, to the southern reaches of Angola. In the western parts of the continent, the plant can be found growing throughout Nigeria. It also maintains a significant presence within West-Central Tropical Africa, including the territory of Cameroon. Finally, its range extends into the Congo, illustrating a widespread presence across the tropical landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Pyrenacantha staudtii is a distinctive shrub characterized by its unique growth habit. This species relies on an obligatory climbing habit to navigate its environment and reach sufficient light.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Pyrenacantha staudtii is a medicinal plant widely utilized in West Africa for treating conditions such as dysmenorrhea and threatened abortion. Chemical investigations into its leaves have revealed a diverse profile of bioactive constituents. Researchers have successfully isolated and characterized 3-carbomethoxypyridine from the methanolic extract of the plant. Additionally, the leaves contain several other important compounds, including 3-pyridinecarboxylic acid, beta-sitosterol, and taraxerol. Together, these phytochemicals contribute to the complex chemical makeup that defines the plant's therapeutic potential.
Conditions
Pyrenacantha staudtii demonstrates significant medicinal potential by treating MCF-7 breast cancer cells through the induction of cell death and anoikis. This plant is particularly noted for its vast potential in the treatment of estrogen receptor positive breast cancer. In addition to its anticancer properties, the aqueous extract of the plant shows significant antiulcer activity against gastric ulcers induced by aspirin and indomethacin. Furthermore, Pyrenacantha staudtii is widely utilized in West African folklore for the treatment of dysmenorrhea. These diverse therapeutic applications highlight the plant's efficacy across multiple physiological conditions.
Preparations
Pyrenacantha staudtii is prepared as an aqueous extract derived from its leaves. This specific plant preparation was utilized in studies to evaluate its potential antiulcer activity. Researchers tested the efficacy of the aqueous extract against various experimental gastric ulcer models in rats. The study compared the performance of this extract to the standard drug cimetidine. Ultimately, the aqueous extract of Pyrenacantha staudtii demonstrated significant effectiveness across all tested ulcer models.
Parts used
Pyrenacantha staudtii is a medicinal plant widely utilized in the West African sub-region for treating conditions such as dysmenorrhea and threatened abortion. Scientific investigations have focused extensively on its leaves to uncover their therapeutic potential and chemical composition. Research demonstrates that an aqueous extract of these leaves possesses significant antiulcer activity across various experimental models. Furthermore, the leaves serve as a source for several bioactive constituents, including xanthine oxidase inhibitors and the alkaloid 3-carbomethoxypyridine. Through the isolation and characterization of these compounds, the medicinal value of the plant's leaf components continues to be validated.